Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yan Wang
Observed name:
Wang, Yan
Institution:
Peking University Shenzhen Hospital
Observed institutions:
Merck & Co., Inc., Rahway, NJ, USA (United States),
Peking University Shenzhen Hospital,
Herbert Irving Comprehensive Cancer Center
ORCID:
0000-0001-5906-7435
Observed ORCID:
0000-0001-5906-7435
OpenAlex ID:
A5100322465
FAM64A is an androgen receptor-regulated feedback tumor promoter in prostate cancer
2021
·
Yingchen Zhou
, Longhua Ou
, et al.
·
Cell Death and Disease
·
27
PDF
TCEAL2 as a Tumor Suppressor in Renal Cell Carcinoma is Associated with the Good Prognosis of Patients
2020
·
Yingchen Zhou
, Yang Zhang
, et al.
·
Cancer Management and Research
·
15
PDF
Bladder Cancer in Exosomal Perspective: Unraveling New Regulatory Mechanisms
2024
·
Cong Yin
, Cen Liufu
, et al.
·
International Journal of Nanomedicine
·
6
PDF
Abstract LB023: Thyroid hormone receptor signaling promotes antiandrogen resistance and bone metastasis in prostate cancer
2022
·
Yan Wang
, Gurrapu Harsha
, et al.
·
Cancer Research
Thyroid Hormone Receptor Signaling Promotes Antiandrogen Resistance and Metastasis in Prostate Cancer
2020
·
Yan Wang
Abstract 599: TMPRSS2-ERG gene fusion sensitizes VCaP human prostate tumors to the fully human anti-IGF-IR monoclonal antibody SCH 717454
2011
·
Brian J. Long
, Patrick Groothuis
, et al.
·
Cancer Research
Show more works
View as search
Works count:
8
Citation count:
48
H-index:
3
I10-index:
2
Year
Topic
Type